Cargando…
BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays
BPA is a chemical commonly used in the production of polymer-based materials that can have detrimental effects on the thyroid gland and impact human reproductive health. Various expensive methods, such as liquid and gas chromatography, have been suggested for detecting BPA. The fluorescence polariza...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296492/ https://www.ncbi.nlm.nih.gov/pubmed/37367029 http://dx.doi.org/10.3390/bios13060664 |
_version_ | 1785063663084765184 |
---|---|
author | Raysyan, Anna Zwigart, Sandro D. Eremin, Sergei A. Schneider, Rudolf J. |
author_facet | Raysyan, Anna Zwigart, Sandro D. Eremin, Sergei A. Schneider, Rudolf J. |
author_sort | Raysyan, Anna |
collection | PubMed |
description | BPA is a chemical commonly used in the production of polymer-based materials that can have detrimental effects on the thyroid gland and impact human reproductive health. Various expensive methods, such as liquid and gas chromatography, have been suggested for detecting BPA. The fluorescence polarization immunoassay (FPIA) is an inexpensive and efficient homogeneous mix-and-read method that allows for high-throughput screening. FPIA offers high specificity and sensitivity and can be carried out in a single phase within a timeframe of 20–30 min. In this study, new tracer molecules were designed that linked the fluorescein fluorophore with and without a spacer to the bisphenol A moiety. To assess the influence of the C6 spacer on the sensitivity of an assay based on the respective antibody, hapten–protein conjugates were synthesized and assessed for performance in an ELISA setup, and this resulted in a highly sensitive assay with a detection limit of 0.05 g/L. The lowest limit of detection was reached by employing the spacer derivate in the FPIA and was 1.0 μg/L, working range from 2 to 155 μg/L. The validation of the methods was conducted using actual samples compared to LC–MS/MS, which served as the reference method. The FPIA and ELISA both demonstrated satisfactory concordance. |
format | Online Article Text |
id | pubmed-10296492 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102964922023-06-28 BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays Raysyan, Anna Zwigart, Sandro D. Eremin, Sergei A. Schneider, Rudolf J. Biosensors (Basel) Article BPA is a chemical commonly used in the production of polymer-based materials that can have detrimental effects on the thyroid gland and impact human reproductive health. Various expensive methods, such as liquid and gas chromatography, have been suggested for detecting BPA. The fluorescence polarization immunoassay (FPIA) is an inexpensive and efficient homogeneous mix-and-read method that allows for high-throughput screening. FPIA offers high specificity and sensitivity and can be carried out in a single phase within a timeframe of 20–30 min. In this study, new tracer molecules were designed that linked the fluorescein fluorophore with and without a spacer to the bisphenol A moiety. To assess the influence of the C6 spacer on the sensitivity of an assay based on the respective antibody, hapten–protein conjugates were synthesized and assessed for performance in an ELISA setup, and this resulted in a highly sensitive assay with a detection limit of 0.05 g/L. The lowest limit of detection was reached by employing the spacer derivate in the FPIA and was 1.0 μg/L, working range from 2 to 155 μg/L. The validation of the methods was conducted using actual samples compared to LC–MS/MS, which served as the reference method. The FPIA and ELISA both demonstrated satisfactory concordance. MDPI 2023-06-19 /pmc/articles/PMC10296492/ /pubmed/37367029 http://dx.doi.org/10.3390/bios13060664 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Raysyan, Anna Zwigart, Sandro D. Eremin, Sergei A. Schneider, Rudolf J. BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays |
title | BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays |
title_full | BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays |
title_fullStr | BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays |
title_full_unstemmed | BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays |
title_short | BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays |
title_sort | bpa endocrine disruptor detection at the cutting edge: fpia and elisa immunoassays |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296492/ https://www.ncbi.nlm.nih.gov/pubmed/37367029 http://dx.doi.org/10.3390/bios13060664 |
work_keys_str_mv | AT raysyananna bpaendocrinedisruptordetectionatthecuttingedgefpiaandelisaimmunoassays AT zwigartsandrod bpaendocrinedisruptordetectionatthecuttingedgefpiaandelisaimmunoassays AT ereminsergeia bpaendocrinedisruptordetectionatthecuttingedgefpiaandelisaimmunoassays AT schneiderrudolfj bpaendocrinedisruptordetectionatthecuttingedgefpiaandelisaimmunoassays |